Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Opko Health is 'Not Rated'. Macroaxis provides Opko Health buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding OPK positions. The advice algorithm takes into account all of Opko Health available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from OPK buy-and-hold prospective. Additionally take a look at Your Equity Center.
For the selected time horizon Opko Health has a risk adjusted performance of (0.12), jensen alpha of (0.83), total risk alpha of (1.68), sortino ratio of 0.0 and treynor ratio of 1.87Macroaxis provides advice on Opko Health to complement and cross-verify current analyst consensus on Opko Health. Our recommendation engine determines the corporation potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Opko Health is not overpriced, please check all Opko Health fundamentals including its Price to Sales, Debt to Equity, Z Score, as well as the relationship between Net Income and Earnings Per Share .
Opko Health Trading Alerts and Improvement Suggestions
|Opko Health is not yet fully synchronised with the market data|
|Opko Health generates negative expected return over the last 30 days|
|Opko Health has high historical volatility and very poor performance|
|The company reported revenue of 990.27M. Net Loss for the year was (153.04M) with profit before overhead, payroll, taxes, and interest of 314.61M.|
|OPKO HEALTH has accumulated about 96.47M in cash with (109.14M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16.|
Opko Health Returns Distribution Density
|Mean Return||0.88||Value At Risk||6.17|
|Potential Upside||4.86||Standard Deviation||4.44|